Who founded Vahaticor?

Vahaticor was founded by Marwan Berrada in 2021.

Who are Vahaticor's investors?

Vahaticor's investors include Intuitive Ventures, S3 Ventures.

How much funding has Vahaticor raised?

Vahaticor has disclosed $21.2M raised across 1 round.

Where is Vahaticor headquartered?

Vahaticor is headquartered in Santa Clara, US.

Vahaticor

Santa Clara, US · Founded 2021 · 3 known investors

Find your way into Vahaticor

76 people in our graph share verified history with the Vahaticor team — schools, employers, funds. One of them is your warm intro.

Collin Wallaceunlockedknows Harry Rowland · together at Georgia Institute of Technology (overlapped)

×2knows the team · via University of Minnesota

×5knows the team · via Georgia Institute of Technology

knows the team · via Edwards Lifesciences

×3knows the team · via Sandia National Laboratories

VahatiCor is developing the A-FLUX Reducer System, an interventional device to treat coronary microvascular dysfunction, a condition affecting millions of patients—particularly women—who experience chest pain and cardiac symptoms despite normal standard angiography results. The company addresses a treatment gap for patients with coronary microvascular dysfunction who do not respond to medical management.

Hardware Healthtech Medical Devices

Founders & leadership

Vahaticor was founded in 2021 by Marwan Berrada.

Marwan Berrada inFounder and ChairmanMarwan Berrada is a biomedical engineer and business development professional with over 20 years of experience in medical device product development and commercialization, with expertise in percutaneous therapies including electrophysiology, structural heart, cardiovascular, and endovascular devices; he holds multiple patents and FDA clearances for medical devices.

Harry Rowland inCEOHarry D. Rowland recently served as co-founder and CEO of Endotronix, where he led development of the Cordella Heart Failure System and raised over $150M in financing before the company's acquisition by Edwards Lifesciences in 2024. He holds a PhD in mechanical engineering from Georgia Institute of Technology and a BS in mechanical engineering and MA in economics from UC Santa Barbara.

Kevin Van BladelinChief Technology Officer

Mark NiggliinChief Commercial Officer

Marwan Berrada-Sounni inBoard of Directors Member and Co-FounderExecutive Officer, Director at Advanced Nanotherapies

Board

Brian R. Smith in 𝕏Board of DirectorsManaging Director at S3 Ventures

Daniel SheehanBoard director

Jerrett CreedBoard director

Bruce SamuelsBoard director

Investors · 3

Intuitive Ventures✓ verifiedSunnyvale

S3 Ventures✓ verifiedAustin · $500K – $15M

Also in the syndicate · 1

Intuitive Surgical, Inc.

Reported raises · per SEC filings

Form D private placements

$21.2M disclosed across 1 round · 2025

▶$21.2MraisedDec 2025 · 19 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Brian R. SmithDirector
Marwan Berrada-SounniExecutive Officer, Director
Daniel SheehanDirector
Jerrett CreedDirector
Bruce SamuelsDirector

Offering amount: $32.4M
Amount sold: $21.2M
First sale: Nov 2025
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Vahaticor went on to found or lead other companies.

Brian SmithDirectorFounded Crossroads Systems Terri BurkeBoard ObserverFounded Protaryx Medical Marwan Berrada-SounniFounder and ChairmanFounded Advanced Nanotherapies

In the news

VahatiCor, Inc. announced that it has received $23 million in funding from S3 Ventures, LLC, Intuitive Surgical, Inc. | MarketScreenermarketscreener.com · Nov 2025

Frequently asked questions

What does Vahaticor do?: VahatiCor is developing the A-FLUX Reducer System, an interventional device to treat coronary microvascular dysfunction, a condition affecting millions of patients—particularly women—who experience chest pain and cardiac symptoms despite normal standard angiography results. The company addresses a treatment gap for patients with coronary microvascular dysfunction who do not respond to medical management.
Who founded Vahaticor?: Vahaticor was founded by Marwan Berrada in 2021.
Who are Vahaticor's investors?: Vahaticor's investors include Intuitive Ventures, S3 Ventures.
How much funding has Vahaticor raised?: Vahaticor has disclosed $21.2M raised across 1 round.
Where is Vahaticor headquartered?: Vahaticor is headquartered in Santa Clara, US.